The FDA has asked all manufacturers of over-the-counter (OTC) non-aspirin NSAIDS (nonsteroidal anti-inflammatory drugs) to update the drug facts label warnings related to cardiovascular risk. This includes ibuprofen (such as Advil® PM and Motrin® PM) and naproxen sodium (such as Aleve® PM). The labeling on our website has been updated to reflect this new guidance. As retailers restock their Advil® PM inventory, you will see the updated label on our product packaging. Continue to follow the directions for use on the product packaging you purchased.